
TidalSense is a venture-backed respiratory technology company founded in 2013, headquartered in Cambridge, UK. The company is dedicated to revolutionizing respiratory care through AI-driven…

TidalSense is a venture-backed respiratory technology company founded in 2013, headquartered in Cambridge, UK. The company is dedicated to revolutionizing respiratory care through AI-driven…
Founded: 2013
Headquarters: Cambridge, UK
Flagship product: N-Tidal™ Diagnose (CE-marked Class IIa)
Technology: Patented CO2 capnography sensor + AI cloud platform
Recent funding: Reported May 2023 round led by BGF and Downing Ventures
Respiratory diagnostics and monitoring (COPD, asthma and related conditions).
2013
Software Development
£7.5M
Reported May 2023 round; other reported investors/backers include Foresight Group and SBRI Healthcare.
£13.0M
Dealroom lists Nov 2023 early VC round reported at £13.0M with investors including Business Growth Fund, Foresight Group, NIHR, Downing, SBRI Healthcare.
“Backed by Business Growth Fund (BGF), Downing Ventures; additional investors include Foresight Group and support from SBRI Healthcare.”
| Company |
|---|
TidalSense is a respiratory technology company with a mission to transform the diagnosis and management of chronic respiratory conditions, such as asthma and COPD. The company has ambitions to enable a population-scale change in respiratory care through global deployment of its technologies.
N-Tidal Diagnose is a first-of-its-kind AI-driven (software medical device) diagnostic test for COPD which uses the company’s unique, patented, sensor technology embedded in the N-Tidal device.
TidalSense is undergoing rapid commercial expansion, following a successful Series A funding round. This expansion is supported by a robust clinical evidence generation programme that runs concurrently with our deployed services in the UK and Netherlands.
To support this growth we are seeking a Head of Commercial Development for the Healthcare Provider market with a deep understanding of, and strong commercial relationships within, the UK and European respiratory diagnostics markets.
You will be joining a passionate, socially motivated and multi-disciplinary team covering engineers, scientists, clinicians, designers, product and usability specialists. This is a unique opportunity for a driven and autonomous individual to drive our market expansion strategy and the adoption of a new generation of regulated AI-enabled medical device products and services that will deliver impact in the real world and change people’s lives. We are seeking someone who is comfortable working in a fast-paced, agile, and diverse team environment, and who is also committed to our mission to revolutionise respiratory medicine.
Job Purpose:
To take full ownership for executing TidalSense’s UK commercial strategy, driving the adoption of N-Tidal Diagnose by securing contracts with NHS Integrated Care Boards (ICBs) and private providers. The role will bridge the gap between clinical pathway transformation and commercial reality, working closely with clinical, market access and marketing teams, to turn interest into sustainable long-term quality revenue. The role holder must balance strategic design with hands-on delivery in a growth stage company.
Beyond the UK TidalSense is uniquely positioned to transform respiratory diagnostics on a global scale, and in the longer term this role will ensure that TidalSense is commercially and strategically positioned for the successful adoption of its medical devices within the diagnostic pathways of non-UK healthcare systems.
Key duties & responsibilities:
Revenue Generation & Commercial Execution (70%)
Market Development & Pathway Optimisation (30%)
Skills & Competencies:
Essential
Desirable
Qualifications & Experience:
Essential
Desirable
Other Requirements
Note to Applicants
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
80,000+
Open Roles
4,000+
New This Week